ID rozhodnutia | ID návrhu | Stupeň | Typ rozhodnutia | Navrhovateľ | Zverejnené | Akcia |
---|---|---|---|---|---|---|
1 2 3 4 5 > >> | ||||||
R 1 | 38 | 1 | R_KON | Ministerstvo zdravotníctva | 15.1.2012 | Detaily |
R 2 | 37 | 1 | R_KON | Ministerstvo zdravotníctva | 15.1.2012 | Detaily |
R 3 | 36 | 1 | R_KON | Ministerstvo zdravotníctva | 15.1.2012 | Detaily |
R 4 | 34 | 1 | R_KON | Ministerstvo zdravotníctva | 15.1.2012 | Detaily |
R 5 | 33 | 1 | R_KON | Ministerstvo zdravotníctva | 15.1.2012 | Detaily |
R 6 | 32 | 1 | R_KON | Ministerstvo zdravotníctva | 15.1.2012 | Detaily |
R 7 | 8 | 1 | R_A1E | PRO.MED.CS PRAHA a.s. | 15.2.2012 | Detaily |
R 8 | 57 | 1 | R_A1E | PRO.MED.CS PRAHA a.s. | 15.2.2012 | Detaily |
R 9 | 99 | 1 | R_A1E | Belupo, s.r.o | 15.2.2012 | Detaily |
R 10 | 101 | 1 | R_A1E | Belupo, s.r.o | 15.2.2012 | Detaily |
R 11 | 103 | 1 | R_A1E | Belupo, s.r.o | 15.2.2012 | Detaily |
R 13 | 168 | 1 | R_A1E | GlaxoSmithKline Biologicals S.A. | 15.2.2012 | Detaily |
R 14 | 188 | 1 | R_A1E | Krka d.d. Novo mesto | 15.2.2012 | Detaily |
R 15 | 269 | 1 | R_A1E | Krka d.d. Novo mesto | 15.2.2012 | Detaily |
R 16 | 270 | 1 | R_A1E | Krka d.d. Novo mesto | 15.2.2012 | Detaily |
R 17 | 271 | 1 | R_A1E | Krka d.d. Novo mesto | 15.2.2012 | Detaily |
R 18 | 272 | 1 | R_A1E | Vipharm S.A. | 15.2.2012 | Detaily |
R 19 | 273 | 1 | R_A1E | Krka d.d. Novo mesto | 15.2.2012 | Detaily |
R 20 | 276 | 1 | R_A1E | Krka d.d. Novo mesto | 15.2.2012 | Detaily |
R 21 | 280 | 1 | R_A1E | Krka d.d. Novo mesto | 15.2.2012 | Detaily |
R 22 | 305 | 1 | R_A1E | Generics (UK) Ltd. | 15.2.2012 | Detaily |
R 23 | 308 | 1 | R_A1E | PharmaSwiss Česká republika s.r.o. | 15.2.2012 | Detaily |
R 24 | 89 | 1 | R_CNH | Eli Lilly ČR, s.r.o. | 15.2.2012 | Detaily |
R 25 | 96 | 1 | R_CNH | Eli Lilly ČR, s.r.o. | 15.2.2012 | Detaily |
R 26 | 311 | 1 | R_A1E | PharmaSwiss Česká republika s.r.o. | 15.2.2012 | Detaily |